88 related articles for article (PubMed ID: 28668840)
1.
Schmeel LC; Schmeel FC; Schmidt-Wolf IGH
Anticancer Res; 2017 Jul; 37(7):3513-3520. PubMed ID: 28668840
[TBL] [Abstract][Full Text] [Related]
2. Flunarizine exhibits in vitro efficacy against lymphoma and multiple myeloma cells.
Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Endo T; Schmidt-Wolf IG
Anticancer Res; 2015 Mar; 35(3):1369-76. PubMed ID: 25750287
[TBL] [Abstract][Full Text] [Related]
3. Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma.
Schmeel LC; Schmeel FC; Schmidt-Wolf IG
Anticancer Res; 2016 Jul; 36(7):3395-400. PubMed ID: 27354598
[TBL] [Abstract][Full Text] [Related]
4. In vitro efficacy of cinnarizine against lymphoma and multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Endo T; Schmidt-Wolf IG
Anticancer Res; 2015 Feb; 35(2):835-41. PubMed ID: 25667464
[TBL] [Abstract][Full Text] [Related]
5. Griseofulvin Efficiently Induces Apoptosis in
Schmeel LC; Schmeel FC; Kim Y; Blaum-Feder S; Schmidt-Wolf IGH
Anticancer Res; 2017 May; 37(5):2289-2295. PubMed ID: 28476794
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma.
Schmeel LC; Schmeel FC; Blaum-Feder S; Schmidt-Wolf IG
Anticancer Res; 2015 Nov; 35(11):5921-6. PubMed ID: 26504016
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Wnt/beta-catenin pathway in multiple myeloma.
Schmeel LC; Schmeel FC; Kim Y; Endo T; Lu D; Schmidt-Wolf IG
Anticancer Res; 2013 Nov; 33(11):4719-26. PubMed ID: 24222106
[TBL] [Abstract][Full Text] [Related]
8. Piceatannol exhibits selective toxicity to multiple myeloma cells and influences the Wnt/ beta-catenin pathway.
Schmeel FC; Schmeel LC; Kim Y; Schmidt-Wolf IG
Hematol Oncol; 2014 Dec; 32(4):197-204. PubMed ID: 24470348
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.
Kim Y; Schmidt M; Endo T; Lu D; Carson D; Schmidt-Wolf IG
In Vivo; 2011; 25(6):887-93. PubMed ID: 22021681
[TBL] [Abstract][Full Text] [Related]
10. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
Liang Y; Li X; He X; Qiu X; Jin XL; Zhao XY; Xu RZ
Eur J Haematol; 2016 Oct; 97(4):371-8. PubMed ID: 26821882
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy of griseofulvin against multiple myeloma.
Kim Y; Alpmann P; Blaum-Feder S; Krämer S; Endo T; Lu D; Carson D; Schmidt-Wolf IG
Leuk Res; 2011 Aug; 35(8):1070-3. PubMed ID: 21112630
[TBL] [Abstract][Full Text] [Related]
12. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.
Holien T; Olsen OE; Misund K; Hella H; Waage A; Rø TB; Sundan A
Eur J Haematol; 2013 Oct; 91(4):339-46. PubMed ID: 23869695
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
[TBL] [Abstract][Full Text] [Related]
14. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-kappaB signaling axis.
Zak Z; Gelebart P; Lai R
Leukemia; 2010 Aug; 24(8):1476-86. PubMed ID: 20520642
[TBL] [Abstract][Full Text] [Related]
15. Targeting Wnt pathway in lymphoma and myeloma cells.
Schmidt M; Sievers E; Endo T; Lu D; Carson D; Schmidt-Wolf IG
Br J Haematol; 2009 Mar; 144(5):796-8. PubMed ID: 19036118
[No Abstract] [Full Text] [Related]
16. Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway.
Wang H; Gong Y; Liang L; Xiao L; Yi H; Ye M; Roy M; Xia J; Zhou W; Yang C; Shen X; Zhang B; Li Z; Liu J; Zhou H; Xiao X
Br J Haematol; 2020 Jun; 189(6):1151-1164. PubMed ID: 32167591
[TBL] [Abstract][Full Text] [Related]
17. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
[TBL] [Abstract][Full Text] [Related]
18. Novel combination of tanshinone I and lenalidomide induces chemo-sensitivity in myeloma cells by modulating telomerase activity and expression of shelterin complex and its associated molecules.
Kumar R; Gupta N; Himani ; Sharma A
Mol Biol Rep; 2018 Dec; 45(6):2429-2439. PubMed ID: 30311125
[TBL] [Abstract][Full Text] [Related]
19. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
Al-Sadoon MK; Rabah DM; Badr G
Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
